Sinocelltech Group (SHSE:688520) Debt-to-Equity : 13.39 (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group Debt-to-Equity?

Sinocelltech Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥1,764 Mil. Sinocelltech Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥972 Mil. Sinocelltech Group's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥204 Mil. Sinocelltech Group's debt to equity for the quarter that ended in Mar. 2025 was 13.39.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Sinocelltech Group's Debt-to-Equity or its related term are showing as below:

SHSE:688520' s Debt-to-Equity Range Over the Past 10 Years
Min: -25.2 Med: -2.88 Max: 18.04
Current: 13.39

During the past 9 years, the highest Debt-to-Equity Ratio of Sinocelltech Group was 18.04. The lowest was -25.20. And the median was -2.88.

SHSE:688520's Debt-to-Equity is ranked worse than
99.41% of 1023 companies
in the Biotechnology industry
Industry Median: 0.14 vs SHSE:688520: 13.39

Sinocelltech Group Debt-to-Equity Historical Data

The historical data trend for Sinocelltech Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group Debt-to-Equity Chart

Sinocelltech Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

1.02

-4.76

-6.99

-4.58

18.04

Sinocelltech Group Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Debt-to-Equity	Get a 7-Day Free Trial															-5.38	-6.47	-21.16	18.04	13.39

Competitive Comparison of Sinocelltech Group's Debt-to-Equity

For the Biotechnology subindustry, Sinocelltech Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinocelltech Group's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinocelltech Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Sinocelltech Group's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Sinocelltech Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Sinocelltech Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1596.886	+	945.458)	/	140.897
	=	18.04

Sinocelltech Group's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1763.857	+	971.904)	/	204.262
	=	13.39

Sinocelltech Group (SHSE:688520) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Sinocelltech Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinocelltech Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176

Website

http://www.sinocelltech.com

Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.

Executives

Xie Liang Zhi

Director

Sinocelltech Group Headlines

No Headlines